Photo from wikipedia
Key Points Question What is the prevalence of HIV preexposure prophylaxis (PrEP) among commercially insured persons with opioid and/or stimulant use disorder by injection drug use (IDU) status? Findings In… Click to show full abstract
Key Points Question What is the prevalence of HIV preexposure prophylaxis (PrEP) among commercially insured persons with opioid and/or stimulant use disorder by injection drug use (IDU) status? Findings In this cross-sectional study of 547 709 commercially insured persons with opioid and/or stimulant use disorder, including 110 592 persons with evidence of IDU, 0.09% of the population overall and 0.15% of those with evidence of IDU received a PrEP prescription. Meaning In this study, HIV PrEP delivery for persons with substance use disorder, including those who inject drugs, remained low.
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!